Central nervous system expression and PET imaging of the translocator protein in relapsing-remitting experimental autoimmune encephalomyelitis

Journal of Nuclear Medicine

Volumn 54, Issue 2, 2013, Pages 291-298

  Mattner, Filomena ^a,b   Staykova, Maria ^c,d   Berghofer, Paula ^a   Wong, Heng Jian ^c   Fordham, Susan ^c   Callaghan, Paul ^a   Jackson, Timothy ^a   Pham, Tien ^a   Gregoire, Marie Claude ^a   Zahra, David ^a   Rahardjo, Gita ^a   Linares, David ^c   Katsifis, Andrew ^b  

^a AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c CANBERRA HOSPITAL   (Australia)

^d Biology and Environment   (Australia)

Author keywords

Experimental autoimmune encephalomyelitis; Inflammation; Multiple sclerosis; PET; Translocator protein

Indexed keywords

CARRIER PROTEIN;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL LABELING; CENTRAL NERVOUS SYSTEM; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; HISTOPATHOLOGY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MACROPHAGE; MICROGLIA; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RELAPSE;

ANIMALS; CENTRAL NERVOUS SYSTEM; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGES; MICE; MICROSCOPY, FLUORESCENCE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; POSITRON-EMISSION TOMOGRAPHY; PROTEIN TRANSPORT; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, GABA;

EID: 84873539337     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.112.108894     Document Type: Article

References (38)

1. Imitola J, Chitnis T, Khoury SJ. Insights into the molecular pathogenesis of progression in multiple sclerosis: potential implications for future therapies. Arch Neurol. 2006;63:25-33.
2. Tsunoda I, Kuang LQ, Theil DJ, Fujinami RS. Antibody association with a novel model for primary progressive multiple sclerosis: induction of relapsing-remitting and progressive forms of EAE in H2s mouse strains. Brain Pathol. 2000;10:402-418.
3. Muller DM, Pender MP, Greer JM. Blood-brain barrier disruption and lesion localisation in experimental autoimmune encephalomyelitis with predominant cerebellar and brainstem involvement. J Neuroimmunol. 2005;160:162-169.
4. Gao Z, Tsirka SE. Animal models of MS reveal multiple roles of microglia in disease pathogenesis. Neurol Res Int. 2011;2011:383087.
5. Lublin FD, Reingold SC. Defining the clinical course of multiple sclerosis: results of an international survey-National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology. 1996;46:907-911.
6. Boretius S, Kasper L, Tammer R, Michaelis T, Frahm J. MRI of cellular layers in mouse brain in vivo. Neuroimage. 2009;47:1252-1260.
7. Chard D, Miller D. Is multiple sclerosis a generalized disease of the central nervous system? An MRI perspective. Curr Opin Neurol. 2009;22:214-218.
8. Barkhof F, Simon JH, Fazekas F, et al. MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials. Nat Rev Neurol. 2012;8:13-21.
9. Papadopoulos V, Baraldi M, Guilarte TR, et al. Translocator protein (18 KDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function. Trends Pharmacol Sci. 2006;27:402-409.
10. Venneti S, Wang GJ, Nguyen J, Wiley CA. The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders. J Neuropathol Exp Neurol. 2008;67:1001-1010.
11. Papadopoulos V, Lecanu L, Brown RC, Han Z, Yao ZX. Peripheral-type benzodiazepine receptor in neurosteroid biosynthesis, neuropathology and neurological disorders. Neuroscience. 2006;138:749-756.
12. Casellas P, Galiegue S, Basile AS. Peripheral benzodiazepine receptors and mitochondrial function. Neurochem Int. 2002;40:475-486.
13. Chen MK, Guilarte TR. Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair. Pharmacol Ther. 2008;118:1-17.
14. Ji B, Maeda J, Sawada M, et al. Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies. J Neurosci. 2008;28:12255-12267.
15. Oh U, Fujita M, Ikonomidou VN, et al. Translocator protein PET imaging for glial activation in multiple sclerosis. J Neuroimmune Pharmacol. 2011;6:354-361.
16. Venneti S, Lopresti BJ, Wiley CA. The peripheral benzodiazepine receptor (translocator protein 18 KDa) in microglia: from pathology to imaging. Prog Neurobiol. 2006;80:308-322.
17. Versijpt JJ, Dumont F, Vanlaere KJ, et al. Assessment of neuroinflammation and microglial activation in Alzheimer's disease with radiolabelled PK11195 and single photon emission computed tomography: a pilot study. Eur Neurol. 2003;50:39-47.
18. Gerhard A, Banati RB, Goerres GB, et al. [C-11](R)-PK11195 PET imaging of microglial activation in multiple system atrophy. Neurology. 2003;61:686-689.
19. Chauveau F, Boutin H, Van Camp N, Dolle F, Tavitian B. Nuclear imaging of neuroinflammation: a comprehensive review of [C-11]PK11195 challengers. Eur J Nucl Med Mol Imaging. 2008;35:2304-2319.
20. 18F]pyrazolo[1,5-a]pyrimidines for the study of the peripheral benzodiazepine receptor using positron emission tomography. J Med Chem. 2008;51:3700-3712.
21. Van Camp N, Boisgard R, Kuhnast B, et al. In vivo imaging of neuroinflammation: a comparative study between [F-18]PBR111, [C-11]CLINME and [C-11] PK11195 in an acute rodent model. Eur J Nucl Med Mol Imaging. 2010;37: 962-972.
22. 18F]PBR102 using the Tracerlab FXFN and Tracerlab MXFDG module for imaging the peripheral benzodiazepine receptor with PET. Appl Radiat Isot. 2012;70:176-183.
23. Disselhorst JA, Brom M, Laverman P, et al. Image-quality assessment for several positron emitters using the NEMA NU 4-2008 standards in the Siemens Inveon small-animal PET scanner. J Nucl Med. 2010;51:610-617.
24. BrainVISA/Anatomist Web page. Available at: http://brainvisa.info. Accessed December 28, 2012.
25. Ne MRMAT (Neurological Atlas) Mouse Brain Database Web page. Available at: http://www.bnl.gov/medical/RCIBI/mouse/. Accessed December 28, 2012.
26. Mattner F, Katsifis A, Staykova M, Ballantyne P, Willenborg DO. Evaluation of a radiolabelled peripheral benzodiazepine receptor ligand in the central nervous system inflammation of experimental autoimmune encephalomyelitis: a possible probe for imaging multiple sclerosis. Eur J Nucl Med Mol Imaging. 2005;32: 557-563.
27. Mattner F, Staykova M, Callaghan P, et al. Assessment of neuroinflammation in transferred EAE via a translocator protein ligand. In: Weissert R, ed. Experimental Autoimmune Encephalomyelitis: Models of Disease Biology and Experimental Therapy. Rijeka, Croatia: InTech; 2012:47-64.
28. Mattner F, Bandin DL, Staykova M, et al. Evaluation of [123I]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation. Eur J Nucl Med Mol Imaging. 2011;38: 1516-1528.
29. Tonra JR, Reiseter BS, Kolbeck R, et al. Comparison of the timing of acute blood-brain barrier breakdown to rabbit immunoglobulin G in the cerebellum and spinal cord of mice with experimental autoimmune encephalomyelitis. J Comp Neurol. 2001;430:131-144.
30. Wuerfel J, Tysiak E, Prozorovski T, et al. Mouse model mimics multiple sclerosis in the clinico-radiological paradox. Eur J Neurosci. 2007;26:190-198.
31. Lees JR, Golumbek PT, Sim J, Dorsey D, Russell JH. Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis. J Exp Med. 2008;205:2633-2642.
32. Sajad M, Zargan J, Chawla R, Umar S, Khan HA. Upregulation of CSPG3 accompanies neuronal progenitor proliferation and migration in EAE. J Mol Neurosci. 2011;43:531-540.
33. Picard-Riera N, Decker L, Delarasse C, et al. Experimental autoimmune encephalomyelitis mobilizes neural progenitors from the subventricular zone to undergo oligodendrogenesis in adult mice. Proc Natl Acad Sci USA. 2002;99:13211-13216.
34. 18KDa) is expressed by neural stem and neuronal precursor cells. Neurosci Lett. 2009;462: 257-262.
35. Ito F, Toyama H, Kudo G, et al. Two activated stages of microglia and PET imaging of peripheral benzodiazepine receptors with [C-11]PK11195 in rats. Ann Nucl Med. 2010;24:163-169.
36. Rasmussen S, Imitola J, Ayuso-Sacido A, et al. Reversible neural stem cell niche dysfunction in a model of multiple sclerosis. Ann Neurol. 2011;69:878-891.
37. Pluchino S, Muzio L, Imitola J, et al. Persistent inflammation alters the function of the endogenous brain stem cell compartment. Brain. 2008;131: 2564-2578.
38. Hanisch UK, Kettenmann H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci. 2007;10:1387-1394.